Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_12-cv-01917/USCOURTS-caed-1_12-cv-01917-5/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

___________________________________1_______________________________

ORDER GRANTING JOINT MOTION TO DISMISS THE CLAIMS AGAINST 

QUALITEST PHARMACEUTICALS DEFENDANTS ONLY 1:12-cv-01917-

LJO-SKO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

EDWARD BALTAZAR, et al.,

Plaintiffs,

v.

MCKESSON CORPORATION, et 

al.,

Defendant.

)

)

)

)

)

)

)

)

)

)

)

CASE NO. 1:12-cv-01917-LJO-SKO

ORDER GRANTING JOINT MOTION TO DISMISS THE CLAIMS AGAINST 

QUALITEST PHARMACEUTICALS DEFENDANTS ONLY

The Plaintiffs in the above-captioned action, and Defendants Endo 

Pharmaceuticals Holdings Inc.; Endo Pharmaceuticals Inc.; Generics International 

(US Parent), Inc.; Generics International (US), Inc.; Generics Bidco I, LLC; 

Generics Bidco II, LLC; Vintage Pharmaceuticals, LLC; Brenn Distribution, Inc. 

Case 1:12-cv-01917-LJO-SKO Document 56 Filed 03/18/16 Page 1 of 3
___________________________________2_______________________________

ORDER GRANTING JOINT MOTION TO DISMISS THE CLAIMS AGAINST 

QUALITEST PHARMACEUTICALS DEFENDANTS ONLY 1:12-cv-01917-

LJO-SKO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

f/k/a Propst Distribution, Inc. f/k/a Qualitest Pharmaceuticals, Inc.; and Brenn 

Manufacturing, Inc. f/k/a Vintage Pharmaceuticals, Inc.1(“Qualitest 

Pharmaceuticals Defendants”), have jointly moved for an order of dismissal. Upon 

consideration of the joint motion, it is hereby

ORDERED as follows:

1. The joint motion is GRANTED.

2. The claims of the Plaintiffs named in Exhibit A shall be and hereby 

are dismissed with prejudice as to the Qualitest Pharmaceuticals Defendants.

3. The claims of the Plaintiffs named in Exhibit B hereto shall be and 

hereby are dismissed without prejudice for 90 days from the date of this Order, at 

which time the dismissal shall automatically convert to with prejudice under 

Federal Rule of Civil Procedure 54(b) without further order of the Court unless 

Plaintiffs shall refile in compliance with the terms and conditions specified below. 

Upon conversion of this dismissal to with prejudice, the Qualitest Pharmaceuticals 

Defendants may, at their option, move this Court for a written order confirming the 

dismissal of Plaintiffs’ claims with prejudice, which motion Plaintiffs shall join 

and/or not oppose.

4. Between the date of this Order and 90 days from the date of this 

Order, Plaintiffs may refile their claims against the Qualitest Pharmaceuticals 

Defendants only if:

a. such refiling is made in the United States District Court for the 

Eastern District of Kentucky; 

 

1Brenn Distribution, Inc., Propst Distribution, Inc., Qualitest Pharmaceuticals, Inc., 

Brenn Manufacturing, Inc. and Vintage Pharmaceuticals, Inc. were erroneously 

named as individual defendants but have appeared in these cases as Brenn 

Distribution, Inc. f/k/a Propst Distribution, Inc. f/k/a Qualitest Pharmaceuticals, 

Inc.; and Brenn Manufacturing, Inc. f/k/a Vintage Pharmaceuticals, Inc.

Case 1:12-cv-01917-LJO-SKO Document 56 Filed 03/18/16 Page 2 of 3
___________________________________3_______________________________

ORDER GRANTING JOINT MOTION TO DISMISS THE CLAIMS AGAINST 

QUALITEST PHARMACEUTICALS DEFENDANTS ONLY 1:12-cv-01917-

LJO-SKO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

b. such refiling alleges in the Complaint that the Plaintiff filled a 

prescription for a propoxyphene-containing medication attributable to the 

Qualitest Pharmaceuticals Defendants, identifies the date and pharmacy at 

which that prescription was filled, attaches as an exhibit all documentary 

evidence supporting that allegation, and produces evidence of a 

Contemporaneous Injury in accordance with and as defined in Romo v. 

McKesson Corp., No. 2:15-0089, CMO 5, section II.A (E.D. Ky. 

[1/26/2016]); and

c. the refiling Plaintiff’s claims have not been released pursuant to 

the nationwide master settlement programs agreed to between Plaintiffs and 

the Qualitest Pharmaceuticals Defendants.

5. For any complaint refiled pursuant to the terms of Paragraph 3 above, 

all defenses to which the Qualitest Pharmaceuticals Defendants were entitled as of 

the effective date of the original complaint in this action against the Qualitest 

Pharmaceuticals Defendants are preserved, except that any defense under the 

statutes of limitations and/or repose shall be evaluated as of the date of the filing of 

the original Complaint, rather than the date of any refiling pursuant to Paragraph 3 

above. 

6. Each party will bear his, her, or its own fees and costs.

7. This Order does not affect the claims of the Plaintiffs against any 

other Defendant.

IT IS SO ORDERED.

Dated: March 18, 2016 /s/ Lawrence J. O’Neill 

UNITED STATES DISTRICT JUDGE

Case 1:12-cv-01917-LJO-SKO Document 56 Filed 03/18/16 Page 3 of 3